PMY — System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony Class II

FDA Device Classification

FDA product code PMY covers "System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony", a Class II medical device regulated under 21 CFR 866.1640. Submissions are reviewed by the Microbiology panel. At least 3 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
PMY
Device Class
Class II
Regulation Number
866.1640
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

To detect the presence of genetic markers of antimicrobial resistance by testing isolated bacterial colonies using nucleic acid amplification technology.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K191288opgenAcuitas AMR Gene PanelSeptember 30, 2021
K190275genepocGenePOC CarbaMay 10, 2019
K152614cepheidXpert Carba-RMarch 7, 2016